X-47565335-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM1BP4_StrongBS2
The NM_001654.5(ARAF):c.542C>A(p.Thr181Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,208,966 control chromosomes in the GnomAD database, including 1 homozygotes. There are 414 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0012 ( 1 hom., 49 hem., cov: 23)
Exomes 𝑓: 0.0011 ( 0 hom. 365 hem. )
Consequence
ARAF
NM_001654.5 missense
NM_001654.5 missense
Scores
1
7
9
Clinical Significance
Conservation
PhyloP100: 1.96
Genes affected
ARAF (HGNC:646): (A-Raf proto-oncogene, serine/threonine kinase) Enables protein serine/threonine kinase activity. Involved in negative regulation of apoptotic process; regulation of TOR signaling; and regulation of cellular protein metabolic process. Predicted to be active in cytosol and mitochondrion. Biomarker of high grade glioma. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
PM1
In a modified_residue Phosphothreonine (size 0) in uniprot entity ARAF_HUMAN
BP4
Computational evidence support a benign effect (MetaRNN=0.017808765).
BS2
High Hemizygotes in GnomAd4 at 49 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARAF | NM_001654.5 | c.542C>A | p.Thr181Asn | missense_variant | 6/16 | ENST00000377045.9 | |
ARAF | NM_001256196.2 | c.551C>A | p.Thr184Asn | missense_variant | 6/16 | ||
ARAF | NM_001256197.2 | c.542C>A | p.Thr181Asn | missense_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARAF | ENST00000377045.9 | c.542C>A | p.Thr181Asn | missense_variant | 6/16 | 1 | NM_001654.5 | P1 | |
ARAF | ENST00000377039.2 | c.542C>A | p.Thr181Asn | missense_variant | 6/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00123 AC: 138AN: 112005Hom.: 1 Cov.: 23 AF XY: 0.00143 AC XY: 49AN XY: 34167
GnomAD3 genomes
AF:
AC:
138
AN:
112005
Hom.:
Cov.:
23
AF XY:
AC XY:
49
AN XY:
34167
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000783 AC: 143AN: 182592Hom.: 0 AF XY: 0.000730 AC XY: 49AN XY: 67138
GnomAD3 exomes
AF:
AC:
143
AN:
182592
Hom.:
AF XY:
AC XY:
49
AN XY:
67138
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00110 AC: 1209AN: 1096908Hom.: 0 Cov.: 31 AF XY: 0.00101 AC XY: 365AN XY: 362312
GnomAD4 exome
AF:
AC:
1209
AN:
1096908
Hom.:
Cov.:
31
AF XY:
AC XY:
365
AN XY:
362312
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00123 AC: 138AN: 112058Hom.: 1 Cov.: 23 AF XY: 0.00143 AC XY: 49AN XY: 34230
GnomAD4 genome
AF:
AC:
138
AN:
112058
Hom.:
Cov.:
23
AF XY:
AC XY:
49
AN XY:
34230
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
6
ExAC
AF:
AC:
80
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 23, 2024 | The c.542C>A (p.T181N) alteration is located in exon 6 (coding exon 5) of the ARAF gene. This alteration results from a C to A substitution at nucleotide position 542, causing the threonine (T) at amino acid position 181 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;D;.
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;M;M
MutationTaster
Benign
N;N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N
REVEL
Uncertain
Sift
Benign
.;T;D
Sift4G
Benign
T;T;D
Polyphen
0.75
.;P;.
Vest4
MVP
MPC
0.16
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at